Victor G. Gian

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: A phase II study

Börje S. Andersson, Ashwin Kashyap, Victor G. Gian et al. · Biology of Blood and Marrow Transplantation · 2002 · 187 citations · Full text

Paclitaxel/carboplatin with or without sorafenib in the first‐line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute

John D. Hainsworth, Dana S. Thompson, John A. Bismayer et al. · Cancer Medicine · 2014 · 56 citations · Full text

Gastroparesis following bone marrow transplantation

DA Eagle, Victor G. Gian, GY Lauwers et al. · Bone Marrow Transplantation · 2001 · 52 citations

Bone Marrow Failure, Transplantation, Hematology +2

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

BS Andersson, James Gajewski, Michèle L. Donato et al. · Bone Marrow Transplantation · 2000 · 47 citations

Regenerative Medicine, Cell Therapy, Transplantation +7

Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: A case report

David Mann, J Moreb, S. Smith et al. · Journal of Infection · 1998 · 39 citations

Invasive Adenovirus Infection, Transplantation, Antiviral Therapy +5